PF-05208756
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-05208756, covering 2016-06-15 to 2017-04-04. Get the full timeline:
Most recent: Clinical Trial Update: PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A [Phase 4]